Are Digital Therapeutics Ready For Prime Time? | Rock Health Summit 2019

“Software as a drug” has cleared some big hurdles: validation studies proving outcomes, FDA approvals, and some mega partnerships with pharma to accelerate validation and commercialization. But major hurdles remain. How do clinically validated companies create a new treatment paradigm, overcoming early skepticism of digital medicine? How are pharma and provider organizations involved, if at all? How do these solutions reach patients? And perhaps most critically—who pays?

Livongo Chief Medical Officer Bimal Shah, Vivante Health Founder & CEO Kim Angelides, Blue Shield of California SVP and CFO Sandra Clarke, and Elektra Labs Co-founder & CEO Andy Coravos discuss the outstanding challenges to digital therapeutic adoption and set the stage for continued transformation (and impact) over the next few years.

The Rock Health Summit is a digital health conference specially designed to bring together over 700 diverse minds from healthcare, technology, venture, policy, research and beyond to explore the future of healthcare.

rockhealth.com

Видео Are Digital Therapeutics Ready For Prime Time? | Rock Health Summit 2019 канала Rock Health